Multifunctional low-frequency magnetotherapy device "MAGNIT-2 - Med TeKo" according to TU 9444-024-56812193-2011 Composed of: 1. Electronic unit - 1 pc. 2. Inductor No1-2 (double disk) - 1 pc. 3. Inductor No3 (cylindrical) - 2 pcs. 4. Inductor No4 (cavity) - 1 pc. 5. Inductor No5 (small solenoid) - 1 pc. 6. Inductor No6 (large solenoid) - 1 pc. 7. Inductor holder No 3 (assembled) - 2 pcs. 8. Magnetic field indicator - 1 pc. 9. Trolley table - 1 pc. (if necessary), consisting of: - trolley table - 1 pc.; - wheel with brake - 4 pcs.; - screw M10x20 - 4 pcs.; - tool for assembling a trolley: - hex wrench - 1 pc. 10. Operational documentation: - passport - 1 pc.; - Instruction manual - 1 pc. - Roszdravnadzor Registration ФСР 2011/10726
Access comprehensive regulatory information for Multifunctional low-frequency magnetotherapy device "MAGNIT-2 - Med TeKo" according to TU 9444-024-56812193-2011 Composed of: 1. Electronic unit - 1 pc. 2. Inductor No1-2 (double disk) - 1 pc. 3. Inductor No3 (cylindrical) - 2 pcs. 4. Inductor No4 (cavity) - 1 pc. 5. Inductor No5 (small solenoid) - 1 pc. 6. Inductor No6 (large solenoid) - 1 pc. 7. Inductor holder No 3 (assembled) - 2 pcs. 8. Magnetic field indicator - 1 pc. 9. Trolley table - 1 pc. (if necessary), consisting of: - trolley table - 1 pc.; - wheel with brake - 4 pcs.; - screw M10x20 - 4 pcs.; - tool for assembling a trolley: - hex wrench - 1 pc. 10. Operational documentation: - passport - 1 pc.; - Instruction manual - 1 pc. in the Russia medical device market through Pure Global AI's free database. This Class 2a medical device is registered under Roszdravnadzor registration number ФСР 2011/10726 and manufactured by ООО "Мед ТеКо". The device was registered on June 27, 2023.
This page provides complete registration details including device type, manufacturer information, country of origin (Russia), and regulatory compliance data from the official Russia Roszdravnadzor medical device database. Pure Global AI offers free access to Russia's complete medical device registry, helping global MedTech companies navigate Roszdravnadzor regulations efficiently.

